Literature DB >> 11737436

Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin.

W Y Jiang1, A D Chattedee, S P Raychaudhuri, S K Raychaudhuri, E M Farber.   

Abstract

BACKGROUND: An important cellular aberration at sites of psoriatic inflammation is an increase in the number of dermal mast cells. Being multifactorial immune effector cells, it is believed that mast cells play an essential role in perpetuating the inflammatory process of psoriasis. However, factors responsible for the infiltration and accumulation of mast cells in psoriatic lesions are largely unknown. Recent studies have demonstrated that Interleukin-8 (IL-8) exerts strong chemotactic effects on mast cells in vitro. Overexpression of IL-8 has also been reported in psoriatic lesions. In this study, we have found a correlation between the expression of IL-8 and dermal mast cell density in lesional psoriatic skin as compared to nonlesional psoriatic skin.
METHODS: Four-mm punch biopsies were taken from 14 psoriatic patients and eight healthy volunteers. Using immunohistochemical techniques, 8 microm sections of lesional psoriatic, nonlesional psoriatic, and normal control samples were evaluated for dermal mast cell density and the density of IL-8 expressing keratinocytes.
RESULTS: It was found that dermal mast cell density in lesional psoriatic, nonlesional psoriatic, and normal skin was 105.4 +/- 71.2, 42.3 +/- 30.1, and 47.5 +/- 32.5 mast cells/mm(2), respectively. IL-8+ keratinocyte density in lesional psoriatic, non lesional psoriatic, and normal skin was 171.5 +/- 67.1, 25.4 +/- 14.9 and 20.6 +/- 8.7 IL-8+ Keratinocytes/mm(2), respectively.
CONCLUSIONS: The results of this study suggest that increased levels of IL-8 in the keratinocytes of psoriatic plaques play a contributing role in the migration of mast cells to lesion sites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737436     DOI: 10.1046/j.1365-4362.2001.01262.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.

Authors:  M Vasiadi; A Therianou; K D Alysandratos; A Katsarou-Katsari; T Petrakopoulou; A Theoharides; E Papadavid; N Stavrianeas; C Antoniou; D Kalogeromitros; T C Theoharides
Journal:  Br J Dermatol       Date:  2012-05-14       Impact factor: 9.302

2.  Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.

Authors:  Marie Fischer; Ilkka T Harvima; Ricardo F S Carvalho; Christine Möller; Anita Naukkarinen; Gunilla Enblad; Gunnar Nilsson
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

Review 3.  Defining mast cell differentiation and heterogeneity through single-cell transcriptomics analysis.

Authors:  Tahereh Derakhshan; Joshua A Boyce; Daniel F Dwyer
Journal:  J Allergy Clin Immunol       Date:  2022-10       Impact factor: 14.290

4.  Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases.

Authors:  Smriti K Raychaudhuri; Siba P Raychaudhuri
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

5.  MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R.

Authors:  Galya Lerman; Camila Avivi; Corine Mardoukh; Aviv Barzilai; Ariel Tessone; Ben Gradus; Felix Pavlotsky; Iris Barshack; Sylvie Polak-Charcon; Arie Orenstein; Eran Hornstein; Yechezkel Sidi; Dror Avni
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

Review 6.  Scanning the Immunopathogenesis of Psoriasis.

Authors:  Andrea Chiricozzi; Paolo Romanelli; Elisabetta Volpe; Giovanna Borsellino; Marco Romanelli
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

7.  Elucidating the immune infiltration in acne and its comparison with rosacea by integrated bioinformatics analysis.

Authors:  Lu Yang; Yan-Hong Shou; Yong-Sheng Yang; Jin-Hua Xu
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

8.  Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin.

Authors:  Zuyi Weng; Arti B Patel; Magdalini Vasiadi; Anastasia Therianou; Theoharis C Theoharides
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  Interferon-γ regulates growth and controls Fcγ receptor expression and activation in human intestinal mast cells.

Authors:  Gernot Sellge; Miriam Barkowsky; Sigrid Kramer; Thomas Gebhardt; Leif E Sander; Axel Lorentz; Stephan C Bischoff
Journal:  BMC Immunol       Date:  2014-07-05       Impact factor: 3.615

Review 10.  Psychological Stress, Mast Cells, and Psoriasis-Is There Any Relationship?

Authors:  Ewelina Woźniak; Agnieszka Owczarczyk-Saczonek; Waldemar Placek
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.